The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada
Open accessAbstract
BACKGROUND: In late spring 2009, concern was raised in Canada that prior vaccination with the 2008-09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of pandemic influenza A (H1N1) (pH1N1) illness. Several epidemiologic investigations were conducted through the summer to assess this putative association. STUDIES INCLUDED: (1) test-negative case-control design based on Canada's sentinel vaccine effectiveness monitoring system in British Columbia, Alberta, Ontario, and Quebec; (2) conventional case-control design using population controls in Quebec; (3) test-negative case-control design in Ontario; and (4) prospective household transmission (cohort) study in Quebec. Logistic regression was used to estimate odds ratios for TIV effect on community- or hospital-based laboratory-confirmed seasonal or pH1N1 influenza cases compared to controls with restriction, stratification, and adjustment for covariates including combinations of age, sex, comorbidity, timeliness of medical visit, prior physician visits, and/or health care worker (HCW) status. For the prospective study risk ratios were computed. Based on the sentinel study of 672 cases and 857 controls, 2008-09 TIV was associated with statistically significant protection against seasonal influenza (odds ratio 0.44, 95% CI 0.33-0.59). In contrast, estimates from the sentinel and three other observational studies, involving a total of 1,226 laboratory-confirmed pH1N1 cases and 1,505 controls, indicated that prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009, with estimated risk or odds ratios ranging from 1.4 to 2.5. Risk of pH1N1 hospitalization was not further increased among vaccinated people when comparing hospitalized to community cases. CONCLUSIONS: Prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009 in Canada. The occurrence of bias (selection, information) or confounding cannot be ruled out. Further experimental and epidemiological assessment is warranted. Possible biological mechanisms and immunoepidemiologic implications are considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903810 · Cited by 3,037
Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., Bautista, E., Ramirez-Venegas, A., Rojas-Serrano, J., Ormsby, C. E., Corrales, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904252 · Cited by 1,325
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,259
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
Itoh, Y., Shinya, K., Kiso, M., Watanabe, T., Sakoda, Y., Hatta, M., Muramoto, Y., Tamura, D., Sakai-Tagawa, Y., Noda, T., et al. (2009) · Nature · doi:10.1038/nature08260 · Cited by 1,073
Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009.
Ginsberg, M. M., Hopkins, J., Maroufi, A., Dunne, G., Sunega, D. R., Giessick, J., McVay, P., Lopez, K., Kriner, P., Munday, S. W., et al. (2009) · PubMed · Cited by 840
Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza
Chowell, G., Bertozzi, S. M., Colchero, M. A., Lopez-Gatell, H., Alpuche-Aranda, C., Hernandez, M., & Miller, M. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904023 · Cited by 684
Field evaluation of vaccine efficacy.
Orenstein, W. A., Bernier, R. H., Tj, D., Hinman, A. R., Js, M., Bart, K. J., & Sirotkin, B. (1985) · Europe PMC (PubMed Central) · Cited by 621
Influenza: old and new threats
Palese, P. (2004) · Nature Medicine · doi:10.1038/nm1141 · Cited by 603
Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009.
(2009) · PubMed · Cited by 571
DISQUISITIONS ON ORIGINAL ANTIGENIC SIN
de St.Groth, S. F., & Webster, R. G. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.3.331 · Cited by 567
Katz, J. D., Hancock, K., Veguilla, V., Zhong, W., Lü, X., Sun, H., Butler, E. N., Dong, L., Liu, F., Li, Z. N., et al. (2009) · MMWR Morbidity and Mortality Weekly Report · Cited by 521
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, K. M., & Weiss, N. S. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyi274 · Cited by 493
Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis
Echevarría-Zuno, S., Mejía-Aranguré, J. M., Mar-Obeso, A. J., Grajales-Muñiz, C., Robles-Pérez, E., González-León, M., Ortega-Alvarez, M. C., Gonzalez-Bonilla, C., Rascón-Pacheco, R. A., & Borja-Aburto, V. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61638-x · Cited by 487
Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Takada, A., & Kawaoka, Y. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.405 · Cited by 332
Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population
Greenbaum, J. A., Kotturi, M. F., Kim, Y., Oseroff, C., Vaughan, K., Salimi, N., Vita, R., Ponomarenko, J., Scheuermann, R. H., Sette, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911580106 · Cited by 317
Jackson, L. A., Nelson, J. C., Benson, P., Neuzil, K. M., Reid, R. J., Psaty, B. M., Heckbert, S. R., Larson, E. B., & Weiss, N. S. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyi275 · Cited by 281
Original Antigenic Sin Responses to Influenza Viruses
Kim, J. H., Skountzou, I., Compans, R., & Jacob, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900398 · Cited by 274
DISQUISITIONS ON ORIGINAL ANTIGENIC SIN
de St.Groth, S. F., & Webster, R. G. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.3.347 · Cited by 210
RODRIGUES, L., & KIRKWOOD, B. R. (1990) · International Journal of Epidemiology · doi:10.1093/ije/19.1.205 · Cited by 207
Skowronski, D. M., Masaro, C., Kwindt, T. L., Mak, A., Petric, M., Li, Y., Sebastian, R., Chong, M., Tam, T., & De Serres, G. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.10.002 · Cited by 202
Self-citationKitikoon, P., Nilubol, D., Erickson, B. J., Janke, B. H., Hoover, T. C., Sornsen, S. A., & Thacker, E. L. (2006) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2006.02.008 · Cited by 194
Kelly, H., & Grant, K. (2009) · Eurosurveillance · doi:10.2807/ese.14.31.19288-en · Cited by 192
The Role of Medical Liability Reform in Federal Health Care Reform
Mello, M. M., & Brennan, T. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0903765 · Cited by 163
Understanding dengue pathogenesis: implications for vaccine design.
Stephenson, J. R. (2005) · Europe PMC (PubMed Central) · Cited by 159
García‐García, L., Valdespino‐Gómez, J. L., Lazcano-Ponce, E. C., Jiménez-Corona, A., Higuera-Iglesias, A. L., Cruz‐Hervert, L. P., Cano‐Arellano, B., Garcia-Anaya, A., Ferreira-Guerrero, E., Báez-Saldaña, R., et al. (2009) · BMJ · doi:10.1136/bmj.b3928 · Cited by 154
Hak, E., Verheij, T. J. M., Grobbee, D. E., Nichol, K. L., & Hoes, A. W. (2002) · Journal of Epidemiology & Community Health · doi:10.1136/jech.56.12.951 · Cited by 143
Skowronski, D. M., Serres, G. D., Dickinson, J., Petric, M., Mak, A., Fonseca, K., Kwindt, T. L., Chan, T., Bastien, N., Charest, H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/595862 · Cited by 134
Self-citationBodewes, R., Kreijtz, J. H. C. M., Baas, C., Geelhoed-Mieras, M. M., de Mutsert, G., van Amerongen, G., van den Brand, J. M. A., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005538 · Cited by 105
Iuliano, A. D., Reed, C., Guh, A. Y., Desai, M., Dee, D. L., Kutty, P. K., Gould, L. H., Sotir, M. J., Grant, G. B., Lynch, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/649555 · Cited by 102
Crum‐Cianflone, N. F., Blair, P. J., Faix, D. J., Arnold, J. C., Echols, S., Sherman, S. S., Tueller, J. E., Warkentien, T. E., Sanguineti, G., Bavaro, M. F., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/648508 · Cited by 101
Original Antigenic Sin in Ferrets: the Response to Sequential Infections with Influenza Viruses
Webster, R. G. (1966) · The Journal of Immunology · doi:10.4049/jimmunol.97.2.177 · Cited by 98
Statement on influenza vaccination for the 2000-2001 season.
Orr, P. (2000) · Canada Communicable Disease Report · Cited by 91
Gargiullo, P. M., Shay, D. K., Katz, J. M., Bramley, A. M., Nowell, M., Michalove, J., Kamimoto, L., Singleton, J. A., Lü, P., Balluz, L. S., et al. (2009) · MMWR Morbidity and Mortality Weekly Report · Cited by 88
Yearly influenza vaccinations: a double-edged sword?
Bodewes, R., Kreijtz, J. H. C. M., & Rimmelzwaan, G. F. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70263-4 · Cited by 84
Janjua, N. Z., Skowronski, D. M., Salway, T. J., Osei, W. D., Adams, E., Petric, M., Sabaiduc, S., Chan, T., Mak, A., Lem, M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656586 · Cited by 73
Self-citationAntibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1
Ochiai, H., Kurokawa, M., Hayashi, K., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.20-26.1988 · Cited by 65
Kobinger, G. P., Meunier, I., Patel, A. R., Pillet, S., Gren, J., Stebner, S., Leung, A., Neufeld, J., Kobasa, D., & von Messling, V. (2010) · The Journal of Infectious Diseases · doi:10.1086/651171 · Cited by 63
Ochiai, H., Kurokawa, M., Matsui, S., Yamamoto, T., Kuroki, Y., Kishimoto, C., & Shiraki, K. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890360312 · Cited by 61
Sauter, P., & Hober, D. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.01.005 · Cited by 53
Ochiai, H., Kurokawa, M., Kuroki, Y., & Niwayama, S. (1990) · Journal of Medical Virology · doi:10.1002/jmv.1890300406 · Cited by 27
Cited by
Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
Dubé, E., Vivion, M., & MacDonald, N. E. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.964212 · Cited by 986
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020) · Nature · doi:10.1038/s41586-020-2538-8 · Cited by 485
Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study
Simonsen, L., Spreeuwenberg, P., Lustig, R., Taylor, R. J., Fleming, D. M., Kroneman, M., Van Kerkhove, M. D., Mounts, A. W., Paget, W. J., & Teams, T. G. C. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001558 · Cited by 485
Skowronski, D. M., Janjua, N. Z., De Serres, G., Sabaiduc, S., Eshaghi, A., Dickinson, J. A., Fonseca, K., Winter, A.-L., Gubbay, J. B., Krajden, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092153 · Cited by 416
Self-citationValenciano, M., Kissling, E., Cohen, J.-M., Oroszi, B., Barret, A.-S., Rizzo, C., Nunes, B., Pitigoi, D., Larrauri Cámara, A., Mosnier, A., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000388 · Cited by 303
Metadata
- Authors
- Skowronski, D. M., De Serres, G., Crowcroft, N. S., Janjua, N. Z., Boulianne, N., Hottes, T. S., Rosella, L. C., Dickinson, J. A., Gilca, R., Sethi, P., Ouhoummane, N., Willison, D. J., Rouleau, I., Petric, M., Fonseca, K., Drews, S. J., Rebbapragada, A., Charest, H., Hamelin, M.-È., Boivin, G., Gardy, J. L., Li, Y., Kwindt, T. L., Patrick, D. M., Brunham, R. C., & for the Canadian SAVOIR Team
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-06
- Volume
- 7
- Issue
- 4
- Pages
- e1000258
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2022168893
- Cited by
- 297
- References
- 43
- FWCI
- 29.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.